GynQura Therapeutics
PrivateLast Round
Grant
Aug 14, 2025
Total Funding Raised
$2.83M
Company Overview
GynQura Therapeutics is a biotechnology company developing non-hormonal, disease-modifying therapies for endometriosis using a patient-derived organoid platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GynQura Therapeutics Comparables
Compare GynQura Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cyclana Bio | 87% | |
| Rosebud Biosciences | 70% | |
| EndoGene.Bio | 66% | |
GynQura Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 14, 2025 | ||||
| Accelerator | Jan 23, 2024 |
GynQura Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EQT Foundation | Grant |
| BioInnovation Institute | Accelerator |
GynQura Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GynQura Therapeutics's valuation, stock price, and market status.